(Q39567775)

13 September 2017

title

The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis (English)

1 reference

13 September 2017

0 references

Catherine E Steding

1

1 reference

13 September 2017

Sung-tse Wu

2

1 reference

13 September 2017

Yanping Zhang

3

1 reference

13 September 2017

Meei-Huey Jeng

4

1 reference

13 September 2017

Bennett D Elzey

5

1 reference

13 September 2017

Chinghai Kao

6

1 reference

13 September 2017

publication date

1 April 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

133

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

221-238

1 reference

The terminology issue for myeloid-derived suppressor cells

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Tumor escape mechanism governed by myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Role of immature myeloid cells in mechanisms of immune evasion in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Myeloid-derived suppressor cell role in tumor-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

The biology of IL-12: coordinating innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

The regulation and biological activity of interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Endogenous IL-12 triggers an antiangiogenic program in melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-gamma, and eradicate tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Ex vivo culture with interleukin (IL)-12 improves CD8(+) T-cell adoptive immunotherapy for murine leukemia independent of IL-18 or IFN-gamma but requires perforin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Biological function and distribution of human interleukin-12 receptor beta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Modulators of arginine metabolism support cancer immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Phorbol ester synergistically increases interferon regulatory factor-1 and inducible nitric oxide synthase induction in interferon-gamma-treated RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Inhibition of interferon-gamma signaling by a mercurio-substituted dihydropsoralen in murine keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Early exposure of high-dose interleukin-4 to tumor stroma reverses myeloid cell-mediated T-cell suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03429.X

Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088984

Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile.

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088984

Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12.

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088984

IL-12 receptor (IL-12R) expression and accumulation of IL-12R beta 1 and IL-12R beta 2 mRNAs in CD4+ T cells by costimulation with B7-2 molecules

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088984

IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis.

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088984

Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088984

Cloning and characterization of a mouse IL-12 receptor-beta component

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088984

IL-12 receptor. II. Distribution and regulation of receptor expression

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088984

IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088984

Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer

4 November 2018

1 reference

12 December 2020

The inhibitory effect of cyclophosphamide-induced MAC-1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR

1 reference

12 December 2020

Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence

1 reference

12 December 2020

Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide

1 reference

12 December 2020

Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production

1 reference

12 December 2020

T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta

1 reference

12 December 2020

IL-12 Acts Directly on DC to Promote Nuclear Localization of NF-κB and Primes DC for IL-12 Production

1 reference

12 December 2020

IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo

1 reference

12 December 2020

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

1 reference

12 December 2020

Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion

1 reference

12 December 2020

10.1111/J.1365-2567.2011.03429.X

Identifiers

DOI

1 reference

13 September 2017

0 references

1 reference